UROwebinar: Difficult bladder cancer cases European School of Urology 57:53 1 year ago 1 255 Далее Скачать
UROwebinar: The Nightmare Cases in Bladder Cancer European School of Urology 56:29 1 month ago 313 Далее Скачать
UROWebinar: New insights in treatment of bladder cancer From localized to metastatic diseases European School of Urology 1:01:52 2 years ago 890 Далее Скачать
Urowebinar: Update on bladder cancer management what are we doing wrong BY MORGAN ROUPRET European School of Urology 45:31 8 years ago 1 610 Далее Скачать
Urowebinar: Practical management of bladder cancer European School of Urology 1:01:32 4 years ago 2 260 Далее Скачать
Urowebinar: Is immune therapy changing the way we think about early bladder cancer? European School of Urology 39:23 5 years ago 398 Далее Скачать
Urowebinar: Time to Cystectomy: Patients' perspective European School of Urology 46:16 5 years ago 775 Далее Скачать
UROwebinar: Bladder neoplasms: Will a morphological classification become obsolete? European School of Urology 1:05:43 3 years ago 1 264 Далее Скачать
Urowebinar: Treatment strategy in muscle invasive bladder cancer European School of Urology 1:00:21 6 years ago 1 302 Далее Скачать
Case-Based Panel Discussion: Muscle-Invasive Bladder Cancer Grand Rounds in Urology 43:17 5 years ago 1 720 Далее Скачать
The Complex Reality of Advanced Bladder Cancer Surgery UroChannel 0:55 2 months ago 383 Далее Скачать
BCG Failure: Defining Failure and Managing Difficult Cases of Non-Muscle Invasive Bladder Cancer Grand Rounds in Urology 9:21 4 years ago 2 518 Далее Скачать
Reasons for bladder removal in bladder cancer | UroChannel UroChannel 0:44 2 years ago 4 240 Далее Скачать
Tanya Dorff, M.D., on Bladder Cancer Treatments | #ASCO21 City of Hope 0:47 3 years ago 2 131 Далее Скачать
UROwebinar En bloc resection of Bladder Tumour ERBT and applied technologies European School of Urology 1:35:15 3 years ago 1 929 Далее Скачать
The difficulties in treating bladder cancer with immunotherapy VJOncology 1:10 5 years ago 954 Далее Скачать
